These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38897557)

  • 1. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study.
    Zhang XY; Gong JY; Wang JS; Feng JY; Chen L; Xie XB; Lu Y
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(7):102392. PubMed ID: 38897557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia.
    Matarazzo L; Di Chio T; Nastasio S; Tommasini A; Ventura A; Maggiore G
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):66-72. PubMed ID: 31076361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell hepatitis associated with autoimmune hemolytic anemia: an update.
    Nastasio S; Matarazzo L; Sciveres M; Maggiore G
    Transl Gastroenterol Hepatol; 2021; 6():25. PubMed ID: 33824929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD20 treatment of giant cell hepatitis with autoimmune hemolytic anemia.
    Paganelli M; Patey N; Bass LM; Alvarez F
    Pediatrics; 2014 Oct; 134(4):e1206-10. PubMed ID: 25201797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
    Whitington PF; Vos MB; Bass LM; Melin-Aldana H; Romero R; Roy CC; Alvarez F
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):74-80. PubMed ID: 23969541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell hepatitis with autoimmune hemolytic anemia in children: proposal for therapeutic approach.
    Bakula A; Socha P; Klaudel-Dreszler M; Karolczyk G; Wozniak M; Rutynowska-Pronicka O; Matysiak M
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):669-73. PubMed ID: 24792633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study.
    Marsalli G; Nastasio S; Sciveres M; Calvo PL; Ramenghi U; Gatti S; Albano V; Lega S; Ventura A; Maggiore G
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):83-9. PubMed ID: 26138133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized rituximab regimen versus recommended regimen for idiopathic membranous nephropathy: A single-center retrospective cohort study.
    Yan P; Fang X; Ke B
    Int Immunopharmacol; 2024 Mar; 130():111718. PubMed ID: 38377859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).
    Michel M; Terriou L; Roudot-Thoraval F; Hamidou M; Ebbo M; Le Guenno G; Galicier L; Audia S; Royer B; Morin AS; Marie Michot J; Jaccard A; Frenzel L; Khellaf M; Godeau B
    Am J Hematol; 2017 Jan; 92(1):23-27. PubMed ID: 27696475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
    Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
    Front Immunol; 2022; 13():915205. PubMed ID: 35844526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
    Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
    Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of giant cell hepatitis and autoimmune hemolytic anemia in infancy].
    Csernus K; Tészás A; Ottóffy G; Dezsőfi-Gottl A; Tárnok A
    Orv Hetil; 2023 Sep; 164(36):1432-1436. PubMed ID: 37695715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study.
    Chen X; Jiao S; Li S; Li J; Li P; Song F; Yan Z
    Balkan Med J; 2023 Jul; 40(4):287-293. PubMed ID: 37260416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
    Hogan J; Godron A; Baudouin V; Kwon T; Harambat J; Deschênes G; Niel O
    Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
    Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly.
    Aqeel F; Xu L; Salas A; Wen Y; Eid SM; Geetha D
    Clin Rheumatol; 2023 Sep; 42(9):2427-2435. PubMed ID: 37225927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Viviano L; Ding L; Iklé D; Villarreal M; Jepson B; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh K; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Stone JH;
    Arthritis Rheumatol; 2014 Nov; 66(11):3151-9. PubMed ID: 25047592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens.
    Wang HH; Liu CW; Li YC; Huang YC
    Acta Derm Venereol; 2015 Nov; 95(8):928-32. PubMed ID: 25881672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study.
    You C; Lamba N; Lasave AF; Ma L; Diaz MH; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1221-1228. PubMed ID: 28154932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.